No. | Questions | Frequency (%) N = 56 |
---|---|---|
1) | Enteric coated [34] Choose the most characteristic feature of this pharmaceutical dosage form: | |
a) Reduce the number of doses needed from the drug and achieve a slow/sustained release of the drug. | 2 (3.6) | |
a b) Aid in the protection of the drug from stomach acidity. | 49 (87.5) | |
c) Used when the patient is susceptible to vomiting. | 0 (0.0) | |
d) I don’t know. | 5 (8.9) | |
2) | Liposomes [32] Choose themost characteristic feature of this pharmaceutical dosage form: | |
a) Used when the patient is susceptible to vomiting. | 1 (1.8) | |
b) Aid in the protection of the drug from stomach acidity. | 2 (3.6) | |
a c) Reduce the side effects of the drug and improve its pharmacokinetic profile. | 31 (55.4) | |
d) I don’t know. | 22 (39.3) | |
3) | Sublingual [30] Choose the most characteristic feature of this pharmaceutical dosage form: | |
a) Reduce the number of doses needed from the drug and achieve a slow/sustained release of the drug. | 0 (0.0) | |
b) Protect the drug from degradation or hydrolysis. | 2 (3.6) | |
a c) Fast drug absorption and protect the drug from hepatic metabolism. | 52 (92.9) | |
d) I don’t know. | 2 (3.6) | |
4) | Nano emulsions [30] Choose the most characteristic feature of this pharmaceutical dosage form: | |
a a) Reduce the number of doses needed from the drug and achieve a slow/sustained release of the drug. | 22 (39.3) | |
b)Aid in the protection of the drug from stomach acidity. | 0 (0.0) | |
c)Used when the patient is susceptible to vomiting. | 4 (7.1) | |
d) I don’t know. | 30 (53.6) | |
5) | Corticosteroid Inhaler [29] Choose the most characteristic feature of this pharmaceutical dosage form: | |
a) Allow the delivery of low water solubility drugs and permit theslow/sustained release of the drug. | 9 (16.1) | |
a b) The drug goes directly to the lungs which reduce the required dose and its side effects. | 43 (76.8) | |
c)Used when the patient is susceptible to vomiting. | 0 (0.0) | |
d) I don’t know. | 4 (7.1) | |
6) | Polymer Nanoparticles [31] Choose the most characteristic feature of this pharmaceutical dosage form: | |
a a) Protect the drug from degradation or hydrolysis. | 24 (42.9) | |
b) The drug goes directly to the lungs which reduces the required dose and its side effects. | 7 (12.5) | |
c)Used when the patient is susceptible to vomiting. | 1 (1.8) | |
d) I don’t know. | 24 (42.9) | |
7) | Suppositories [27] Choose the most characteristic feature of this pharmaceutical dosage form: | |
a) Protect the drug from degradation or hydrolysis. | 7 (12.5) | |
b) Reduce the number of doses needed from the drug and achieve a slow/sustained release of the drug. | 2 (3.6) | |
a c) Used when the patient is susceptible to vomiting. | 44 (78.6) | |
d) I don’t know. | 3 (5.4) | |
8) | Nano crystal dispersion [28] Choose the most characteristic feature of this pharmaceutical dosage form: | |
a)Aid in the protection of the drug from stomach acidity. | 4 (7.1) | |
a b) Allow the delivery of low water solubility drugs and permit the slow/sustained release of the drug. | 25 (44.6) | |
c) Used when the patient is susceptible to vomiting. | 0 (0.0) | |
d) I don’t know. | 27 (48.2) |